Id |
Subject |
Object |
Predicate |
Lexical cue |
T1063 |
0-217 |
Sentence |
denotes |
Gene polymorphisms of opioid (OPRM1 and OPRK1) and non-opioid (e.g., DRD1 and DRD2) drug/neurotransmitter receptor genes are associated with altered HIV infectivity, viral loads and CD4+ cell counts (Proudnikov et al. |
T1064 |
218-236 |
Sentence |
denotes |
2012; Regan et al. |
T1065 |
237-256 |
Sentence |
denotes |
2012; Jacobs et al. |
T1066 |
257-280 |
Sentence |
denotes |
2013; Proudnikov et al. |
T1067 |
281-299 |
Sentence |
denotes |
2013; Dever et al. |
T1068 |
300-306 |
Sentence |
denotes |
2014). |
T1069 |
307-388 |
Sentence |
denotes |
Not only do MORs mediate the behavioral consequences of opiate abuse (Bond et al. |
T1070 |
389-407 |
Sentence |
denotes |
1998; Szeto et al. |
T1071 |
408-426 |
Sentence |
denotes |
2001; Ikeda et al. |
T1072 |
427-445 |
Sentence |
denotes |
2005; Kreek et al. |
T1073 |
446-461 |
Sentence |
denotes |
2005; Xu et al. |
T1074 |
462-673 |
Sentence |
denotes |
2014b), but the ability of MOR to modulate HIV chemokine co-receptor signaling through cross desensitization or through direct molecular interactions suggest MOR may influence HIV infectivity at multiple levels. |
T1075 |
674-915 |
Sentence |
denotes |
The unique ability of MOR to modulate HIV co-receptor function, prompted inquiry regarding whether variants of the OPRM1 gene (polymorphisms or splicing variants) might differentially effect HIV infectivity and/or opiate addictive behaviors. |
T1076 |
916-1103 |
Sentence |
denotes |
In a sample of 1031 HIV-1-infected women, 18 OPRM1 polymorphisms were significantly associated with decreases or increases in HIV infectivity and responsiveness to cART (Proudnikov et al. |
T1077 |
1104-1110 |
Sentence |
denotes |
2012). |
T1078 |
1111-1218 |
Sentence |
denotes |
Other gene polymorphisms, such as enzymes affecting drug metabolism (Meyer and Zanger 1997; Benowitz et al. |
T1079 |
1219-1336 |
Sentence |
denotes |
2006) and other neurochemical systems (Herman and Balogh 2012; Koob and Volkow 2016) can also affect drug dependence. |
T1080 |
1337-1498 |
Sentence |
denotes |
The A118G variant of OPRM1 alters the regulation of proinflammatory cytokine secretion (i.e., TNF-α, IL-10, IFN-γ) from peripheral immune cells (Matsunaga et al. |
T1081 |
1499-1505 |
Sentence |
denotes |
2009). |
T1082 |
1506-1629 |
Sentence |
denotes |
Overall, these findings suggest that polymorphisms in MOR ligands/genes (OPRM1) can influence the pathophysiology of HIV-1. |